Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

QUAKER CHEMICAL CORP Director's Dealing 2014

Nov 3, 2014

31579_dirs_2014-11-03_cd568874-0e67-4900-add8-6886121af336.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: QUAKER CHEMICAL CORP (KWR)
CIK: 0000081362
Period of Report: 2014-10-31

Reporting Person: BARRY MICHAEL F (Director, Chairman, CEO and President)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2014-10-31 Common Stock M 5908 $37.37 Acquired 146204 Direct
2014-10-31 Common Stock S 5908 $82.0632 Disposed 140296 Direct
2014-10-31 Common Stock M 5352 $38.13 Acquired 145648 Direct
2014-10-31 Common Stock S 5352 $82.0632 Disposed 140296 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2014-10-31 Employee Stock Option (right to buy) $37.37 M 5908 Disposed 2018-03-01 Common Stock (5908) Direct
2014-10-31 Employee Stock Option (right to buy) $38.13 M 5352 Disposed 2019-03-06 Common Stock (5352) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 1367 Indirect
Common Stock 32226 Indirect

Footnotes

F1: The sale of shares reported for this transaction was effected pursuant to a Rule 10b5-1 Plan entered into by reporting person on March 10, 2014.

F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $82.00 to $82.41, inclusive. The reporting person undertakes to provide to Quaker Chemical Corporation ("Quaker"), any security holder of Quaker, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.

F3: Information based on reporting person's Plan Statement dated September 30, 2014.

F4: The options for this grant vested in three annual installments: 5,909 shares on March 1, 2012; 5,909 shares on March 1, 2013; and 5,908 shares on March 1, 2014.

F5: The options for this grant vest in three annual installments: 5,352 shares on March 6, 2013; 5,352 shares on March 6, 2014; and 5,351 shares on March 6, 2015.